This map shows the geographic impact of KC Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KC Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KC Anderson more than expected).
This network shows the impact of papers produced by KC Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KC Anderson. The network helps show where KC Anderson may publish in the future.
Co-authorship network of co-authors of KC Anderson
This figure shows the co-authorship network connecting the top 25 collaborators of KC Anderson.
A scholar is included among the top collaborators of KC Anderson based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with KC Anderson. KC Anderson is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Tai, YT, Klaus Podar, Reshma Shringarpure, et al.. (2003). Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3-kinase/AKT signaling beta.. Blood. 102(11).33 indexed citations
6.
Shringarpure, Reshma, D Chauhan, Renate Burger, et al.. (2003). Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications.. Blood. 102(11).1 indexed citations
7.
Chauhan, D, Klaus Podar, Teru Hideshima, et al.. (2003). Targeting mitochondria to overcome conventional and Bortezomib-resistance in multiple myeloma cells.. Blood. 102(11).2 indexed citations
8.
Podar, Klaus, Gustavo Mostoslavsky, YT Tai, et al.. (2003). Critical role for Hck-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin-6-induced proliferation and survival of multiple myeloma cells.. Blood. 102(11).1 indexed citations
LeBlanc, Richard, Teru Hideshima, Tateki Hayashi, et al.. (2002). Thalidomide analogue IMiD3 provides T cell co-stimulation through B7-CD28 pathway.. Blood. 100(11).1 indexed citations
11.
Chauhan, D, Teru Hideshima, Klaus Podar, et al.. (2002). Heat shock protein-27 confers drug-resistance in multiple myeloma cells.. Blood. 100(11).2 indexed citations
12.
Chauhan, D, Michael Sattler, Teru Hideshima, et al.. (2001). 2-methoxyestradiol (2ME2) acts directly on tumor cells and in the bone marrow microenvironment to overcome drug resistance in multiple myeloma (MM) cells.. Blood. 98(11).3 indexed citations
13.
LeBlanc, Richard, et al.. (2001). Proteasome inhibitor PS-341 inhibits human multiple myeloma cell growth in a murine model.. Blood. 98(11).11 indexed citations
14.
Richardson, PG, RL Schlossman, Teru Hideshima, et al.. (2001). A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM).. Blood. 98(11). 77516.23 indexed citations
15.
Gupta, Tapas K. Das, Richard LeBlanc, Klaus Podar, et al.. (2001). beta-Lapachone is safe and effective in Biege-Nude-Xid mouse xenograft model of human plasmacytoma.. Blood. 98(11).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.